Alicia F C Okines (Alicia Okines)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Venues

Cancers

British journal of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

Royal Marsden NHS Foundation Trust

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Royal Marsden NHS Foundation Trust Sep 15 2015

United Kingdom

Consultant Medical Oncologist :: Medicine

Publications

Daire Hanna, Sophie Merrick, Aruni Ghose, Michael John Devlin, Dorothy D Yang, Edward Phillips, Alicia F C Okines, Neha Chopra, Elisavet Papadimatraki, Kirsty Ross, Iain R J Macpherson, Zhuang Y Boh, Caroline O Michie, Angela Swampillai, Sunnia Gupta, Tim Robinson, Lewis Germain, Christopher Tweleves, Charlotte Atkinson, Apostolos Konstantis, Pippa Riddle, Nicola Cresti, Jay D Naik, Annabel Borley, Amy Guppy, Peter Schmid, Melissa Phillips
Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom. British journal of cancer 130 (12) (2024)
Iseult M Browne, Alicia F C Okines
Resistance to Targeted Inhibitors of the PI3K/AKT/mTOR Pathway in Advanced Oestrogen-Receptor-Positive Breast Cancer. Cancers 16 (12) (2024)
Daire Hanna, Sophie Merrick, Aruni Ghose, Michael John Devlin, Dorothy D Yang, Edward Phillips, Alicia F C Okines, Neha Chopra, Elisavet Papadimatraki, Kirsty Ross, Iain R J Macpherson, Zhuang Y Boh, Caroline O Michie, Angela Swampillai, Sunnia Gupta, Tim Robinson, Lewis Germain, Christopher Tweleves, Charlotte Atkinson, Apostolos Konstantis, Pippa Riddle, Nicola Cresti, Jay D Naik, Annabel Borley, Amy Guppy, Peter Schmid, Melissa Phillips
Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom. British journal of cancer 130 (12) (2024)
Edward Phillips, Mantegh Sethi, Surammiya Vasanthakumar, Gina Sherpa, Stephen Johnston, Marina Parton, Emma Kipps, Nicholas C Turner, Matthew Foxton, Alicia F C Okines
The Clinical Features and Outcomes of Pseudocirrhosis in Breast Cancer. Cancers 16 (16) (2024)
Edward Phillips, Mantegh Sethi, Surammiya Vasanthakumar, Gina Sherpa, Stephen Johnston, Marina Parton, Emma Kipps, Nicholas C Turner, Matthew Foxton, Alicia F C Okines
The Clinical Features and Outcomes of Pseudocirrhosis in Breast Cancer. Cancers 16 (16) (2024)
Daire Hanna, Sophie Merrick, Aruni Ghose, Michael John Devlin, Dorothy D Yang, Edward Phillips, Alicia F C Okines, Neha Chopra, Elisavet Papadimatraki, Kirsty Ross, Iain R J Macpherson, Zhuang Y Boh, Caroline O Michie, Angela Swampillai, Sunnia Gupta, Tim Robinson, Lewis Germain, Christopher Tweleves, Charlotte Atkinson, Apostolos Konstantis, Pippa Riddle, Nicola Cresti, Jay D Naik, Annabel Borley, Amy Guppy, Peter Schmid, Melissa Phillips
Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom. British journal of cancer 130 (12) (2024)
Iseult M Browne, Alicia F C Okines
Resistance to Targeted Inhibitors of the PI3K/AKT/mTOR Pathway in Advanced Oestrogen-Receptor-Positive Breast Cancer. Cancers 16 (12) (2024)
Daire Hanna, Sophie Merrick, Aruni Ghose, Michael John Devlin, Dorothy D Yang, Edward Phillips, Alicia F C Okines, Neha Chopra, Elisavet Papadimatraki, Kirsty Ross, Iain R J Macpherson, Zhuang Y Boh, Caroline O Michie, Angela Swampillai, Sunnia Gupta, Tim Robinson, Lewis Germain, Christopher Tweleves, Charlotte Atkinson, Apostolos Konstantis, Pippa Riddle, Nicola Cresti, Jay D Naik, Annabel Borley, Amy Guppy, Peter Schmid, Melissa Phillips
Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom. British journal of cancer (2024)
Vasileios Angelis, Alicia F C Okines
Systemic Therapies for HER2-Positive Advanced Breast Cancer. Cancers 16 (1) (2023)
Vasileios Angelis, Alicia F C Okines
Systemic Therapies for HER2-Positive Advanced Breast Cancer. Cancers 16 (1) (2023)
Maria Coakley, Guillermo Villacampa, Prithika Sritharan, Claire Swift, Kathryn Dunne, Lucy Suzanne Kilburn, Katie Goddard, Christodoulos Pipinikas, Patricia Rojas, Warren Emmett, Peter S Hall, Catherine Harper-Wynne, Tamas Hickish, Iain R J Macpherson, Alicia F C Okines, Andrew M Wardley, Duncan A Wheatley, Simon H Waters, Carlo Palmieri, Matthew C Winter, Rosalind J Cutts, Isaac Garcia-Murillas, Judith M Bliss, Nicholas C Turner
Comparison of circulating tumor DNA assays for Molecular Residual Disease detection in early-stage triple negative breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Laura Morrison, Alicia F C Okines
Systemic Therapy for Metastatic Triple Negative Breast Cancer: Current Treatments and Future Directions. Cancers 15 (15) (2023)
Yoshiaki Nakamura, Nobumasa Mizuno, Yu Sunakawa, Jean-Luc Canon, Matthew D Galsky, Erika Paige Hamilton, Hidetoshi Hayashi, Guy Jerusalem, Seung Tae Kim, Keun-Wook Lee, Lionel Aurelien Kankeu Fonkoua, Bradley J Monk, Danny Nguyen, Do Youn Oh, Alicia F C Okines, David M O'Malley, Paula Pohlmann, Martin Reck, Sang Joon Shin, Kazuki Sudo, Shunji Takahashi, Cedric Van Marcke, Evan Y Yu, Roman Groisberg, Jorge Ramos, Sherry Tan, Thomas Eldridge Stinchcombe, Tanios S Bekaii-Saab
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Alicia F C Okines, Nicholas C Turner
Heterogeneous HER2 Amplification-a New Clinical Category of HER2-Positive Breast Cancer? Cancer discovery 11 (10) (2022)
Alicia F C Okines, Tazia Irfan, Bernice Asare, Kabir Mohammed, Peter Osin, Ashutosh Nerurkar, Ian E Smith, Marina Parton, Alistair Ring, Stephen Johnston, Nicholas C Turner
Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experience. Breast cancer research and treatment 192 (3) (2022)
Amanda Fitzpatrick, Marjan Iravani, Adam Mills, Lucy Childs, Thanussuyah Alaguthurai, Angela Clifford, Isaac Garcia-Murillas, Steven Van Laere, Luc Dirix, Mark Harries, Alicia F C Okines, Nicholas C Turner, Syed Haider, Andrew N J Tutt, Clare M Isacke
Assessing CSF ctDNA to Improve Diagnostic Accuracy and Therapeutic Monitoring in Breast Cancer Leptomeningeal Metastasis. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (6) (2022)
Niamh Cunningham, Scott Shepherd, Kabir Mohammed, Karla A Lee, Mark Allen, Stephen Johnston, Emma Kipps, Sophie McGrath, Jillian Noble, Marina Parton, Alistair Ring, Nicholas C Turner, Alicia F C Okines
Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital. Breast cancer research and treatment 195 (3) (2022)
Alicia F C Okines, Emma Kipps, Tazia Irfan, Maria Coakley, Vaselios Angelis, Bernice Asare, Kabir Mohammed, Geraldine Walsh, Alistair Ring, Stephen R D Johnston, Marina Parton, Nicholas C Turner, Ian E Smith
Impact of timing of adjuvant chemothapy for early breast cancer: the Royal Marsden Hospital experience. British journal of cancer 125 (2) (2021)
Javier Pascual, Joline S J Lim, Iain R J Macpherson, Anne C Armstrong, Alistair Ring, Alicia F C Okines, Rosalind J Cutts, Maria Teresa Herrera-Abreu, Isaac Garcia-Murillas, Alex Pearson, Sarah Hrebien, Heidrun Gevensleben, Paula Z Proszek, Michael Hubank, Margaret Hills, Jenny King, Mona Parmar, Toby Prout, Laura Finneran, Jason Malia, Karen E Swales, Ruth Ruddle, Florence I Raynaud, Alison Turner, Emma C Hall, Timothy Anthony Yap, Juanita S Lopez, Nicholas C Turner
Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in PIK3CA-Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid Cancers. Cancer discovery 11 (1) (2020)
Alicia F C Okines, Tazia Irfan, Komel Khabra, Ian Smith, Mary O'Brien, Marina Parton, Jill Noble, Susie Stanway, Navita Somaiah, Alistair Ring, Stephen Johnston, Nicholas Turner
Development and responses of brain metastases during treatment with trastuzumab emtansine (T-DM1) for HER2 positive advanced breast cancer: A single institution experience. The breast journal 24 (3) (2017)

Alicia F C Okines.css-eqlu8i{font-size:small;padding-left:4px;} (Alicia Okines)

Publication Activity (10 Years)

Top Topics

Top Venues

Alicia F C Okines (Alicia Okines)